Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women. 2023

Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

BACKGROUND Sex hormone (SH) imbalances have been linked to a higher risk of heart failure in both sexes. However, mechanisms that underlie this relationship remain unclear. We examined the association of baseline SH with interstitial and replacement myocardial fibrosis in the MESA (Multi-Ethnic Study of Atherosclerosis) using cardiac magnetic resonance (CMR) T1 mapping and late gadolinium enhancement (LGE). OBJECTIVE The purpose of this study was to assess the link between baseline sex hormone levels and myocardial fibrosis in the MESA cohort using CMR. METHODS A total of 2,324 participants (men and postmenopausal women [PMW]) were included in the MESA with SH measured at baseline and had underwent CMR 10 years later. All analyses were stratified by sex and age. Regression models were constructed to assess the associations of baseline SH with extracellular volume (ECV)% and native T1 time and with LGE. Higher native T1 time and ECV% are interpreted as evidence of increasing interstitial myocardial fibrosis (IMF). Given the limited number of myocardial scars present in PMW, analysis of LGE was limited to men. RESULTS Among older men (age ≥65 years), a 1-SD increment higher free testosterone was significantly associated with 2.45% lower ECV% and 21.5% lower native T1 time, while a 1-SD increment higher bioavailable testosterone was associated with 12.5% lower native T1 time. A 1-SD increment greater sex hormone-binding globulin level was associated with 1% higher ECV%. Among PMW of 55 to 64 years, a 1-SD increment higher total testosterone was associated with 9.5% lower native T1 time. Higher levels of estradiol in older men were independently associated with higher odds of having a myocardial scar (OR: 4.10; 95% CI: 1.35-12.40; P = 0.01). CONCLUSIONS Among older men, SH imbalances at initial evaluation were independently associated with CMR defined IMF and replacement fibrosis, respectively; while increasing total testosterone in middle-aged PMW was associated with lesser marker of IMF. (JACC Adv 2023;2:100320) Published by Elsevier on behalf of the American College of Cardiology Foundation.

UI MeSH Term Description Entries

Related Publications

Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
November 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
March 2001, The Journal of clinical endocrinology and metabolism,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
June 2007, European journal of endocrinology,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
November 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
January 2004, British journal of cancer,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
July 1979, Journal of steroid biochemistry,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
October 2015, Journal of the National Cancer Institute,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
January 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
August 1997, Journal of human hypertension,
Omar Chehab, and Mahsima Shabani, and Vinithra Varadarajan, and Collin O Wu, and Karol E Watson, and Joseph Yeboah, and Wendy S Post, and Bharath Ambale-Venkatesh, and David A Bluemke, and Erin Michos, and João A C Lima
December 2013, African journal of medicine and medical sciences,
Copied contents to your clipboard!